Clinical Trial: A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention

U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07798284) titled 'A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention' on Aug. 27.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled Phase 1b clinical study. All trial participants are required to use TQF3250 capsules or placebo. The aim is to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of multiple administrations of TQF3250 capsules. A total of 80 trial participants are required.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Overweight/Obesity

Intervention:...